DE69524241T2 - 2,7,-substituierte octahydro-1h-pyrido[1,2-a]pyrazin derivate - Google Patents

2,7,-substituierte octahydro-1h-pyrido[1,2-a]pyrazin derivate

Info

Publication number
DE69524241T2
DE69524241T2 DE69524241T DE69524241T DE69524241T2 DE 69524241 T2 DE69524241 T2 DE 69524241T2 DE 69524241 T DE69524241 T DE 69524241T DE 69524241 T DE69524241 T DE 69524241T DE 69524241 T2 DE69524241 T2 DE 69524241T2
Authority
DE
Germany
Prior art keywords
pct
pyrido
pyrazine derivatives
sec
substituted octahydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69524241T
Other languages
English (en)
Other versions
DE69524241D1 (de
Inventor
A Desai
F Fliri
A Sanner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE69524241D1 publication Critical patent/DE69524241D1/de
Publication of DE69524241T2 publication Critical patent/DE69524241T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
DE69524241T 1994-09-30 1995-08-24 2,7,-substituierte octahydro-1h-pyrido[1,2-a]pyrazin derivate Expired - Lifetime DE69524241T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31547094A 1994-09-30 1994-09-30
PCT/IB1995/000689 WO1996010571A1 (en) 1994-09-30 1995-08-24 2,7-SUBSTITUTED OCTAHYDRO-1H-PYRIDO[1,2-a]PYRAZINE DERIVATIVES

Publications (2)

Publication Number Publication Date
DE69524241D1 DE69524241D1 (de) 2002-01-10
DE69524241T2 true DE69524241T2 (de) 2002-06-13

Family

ID=23224581

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69524241T Expired - Lifetime DE69524241T2 (de) 1994-09-30 1995-08-24 2,7,-substituierte octahydro-1h-pyrido[1,2-a]pyrazin derivate

Country Status (34)

Country Link
US (1) US5852031A (de)
EP (1) EP0783503B1 (de)
JP (1) JP3287574B2 (de)
KR (1) KR100244848B1 (de)
CN (1) CN1068327C (de)
AT (1) ATE209648T1 (de)
AU (1) AU681310B2 (de)
BR (1) BR9504230A (de)
CA (1) CA2200959C (de)
CO (1) CO4410335A1 (de)
CZ (1) CZ285090B6 (de)
DE (1) DE69524241T2 (de)
DK (1) DK0783503T3 (de)
ES (1) ES2166830T3 (de)
FI (1) FI113655B (de)
HR (1) HRP950507B1 (de)
HU (1) HUT77354A (de)
IL (1) IL115384A (de)
MX (1) MX9702350A (de)
MY (1) MY113729A (de)
NO (1) NO308995B1 (de)
NZ (1) NZ290936A (de)
PE (1) PE47196A1 (de)
PL (1) PL180899B1 (de)
PT (1) PT783503E (de)
RU (1) RU2163239C2 (de)
SI (1) SI9520096A (de)
SK (1) SK284341B6 (de)
TR (1) TR199501194A2 (de)
TW (1) TW406081B (de)
UA (1) UA50720C2 (de)
WO (1) WO1996010571A1 (de)
YU (1) YU63795A (de)
ZA (1) ZA958223B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231833B1 (en) * 1999-08-05 2001-05-15 Pfizer Inc 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
US6992188B1 (en) 1995-12-08 2006-01-31 Pfizer, Inc. Substituted heterocyclic derivatives
PT874849E (pt) * 1995-12-21 2002-01-30 Pfizer Derivados octa-hidro-pirrolo¬1,2-a|pirazina 2,7-substituidos
US6281216B1 (en) * 1998-02-09 2001-08-28 Duphar International Research B.V. 2-aminoquinoline derivatives having d4-agonistic activity
EP0953567A3 (de) 1998-04-29 2003-04-02 Pfizer Products Inc. Bizyklisch substituierte Piperazin-, Piperidin- und Tetrahydropyridin Derivate, deren Herstellung und deren Verwendung als Mittel mit zentraler dopaminerger (Dopamin D4 Rezeptor) Aktivität
GT199900060A (es) * 1998-05-22 2000-10-14 Polimorfos de un monoclorhidrato de pirazina cristalino y sus composiciones farmacèuticas.
GB0010757D0 (en) 2000-05-05 2000-06-28 Astrazeneca Ab Chemical compounds
GB0011013D0 (en) * 2000-05-09 2000-06-28 Astrazeneca Ab Chemical compounds
EP1177792A3 (de) * 2000-07-27 2002-10-23 Pfizer Products Inc. Dopamin-d4-ligande zur behandlung von gaudi-suchenden krankheiten
US6670476B2 (en) 2000-11-29 2003-12-30 Pfizer Inc. Resolution of trans-7-(hydroxy-methyl)octa-hydro-2H-pyrido[1,2-a]pyrazine
GB0121941D0 (en) 2001-09-11 2001-10-31 Astrazeneca Ab Chemical compounds

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3388128A (en) * 1965-09-03 1968-06-11 Allan R. Day Substituted 1, 4-diazabicyclo [4. 4. 9] decanes
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
US4517187A (en) * 1982-10-18 1985-05-14 Pennwalt Corporation 1,3,4,6,7-11b-Hexahydro-7-phenyl-2H-pyrazino[2,1-a]isoquinolines methods of preparation, and use as antidepressants
DE3564683D1 (en) * 1984-08-07 1988-10-06 Cortial 4-(arylpiperazinylethylaminoethoxy) phenol derivatives, process for their preparation and their therapeutical application
US4704390A (en) * 1986-02-13 1987-11-03 Warner-Lambert Company Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents
IT1204803B (it) * 1986-02-17 1989-03-10 Acraf Composto farmacologicamente attivo e composizioni farmaceutiche che lo contengono,procedimento per prepararlo e intermedio utile in detto procedimento
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
SE8803429D0 (sv) * 1988-09-28 1988-09-28 Pharmacia Ab Novel pyridyl- and pyrimidyl derivatives
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
DE69108743T2 (de) * 1991-01-31 1995-08-17 Pfizer Recematspaltung von trans-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido[1,2-a]-pyrazin.
DK0573464T3 (da) * 1991-02-27 1997-09-01 Pfizer Fremgangsmåde til fremstilling af trans-piperidin-2,5-dicarboxylater
US5185449A (en) * 1991-02-27 1993-02-09 Pfizer Inc. Process and intermediate for certain bis-aza-bicyclic anxiolytic agents
US5157034A (en) * 1991-02-27 1992-10-20 Pfizer Inc. Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
CA2118936A1 (en) * 1991-09-25 1993-04-01 Gene M. Bright Neuroleptic 2-substituted perhydro-1-h-pyrido[1,2-a]pyrazines
WO1993025552A1 (en) * 1992-06-16 1993-12-23 Pfizer Inc. Process and intermediates for bis-aza-bicyclic anxiolytic agents
US5670522A (en) * 1992-10-23 1997-09-23 Merck Sharp & Dohme Limited Dopamine receptor subtype ligands
US5631269A (en) * 1992-10-23 1997-05-20 Merck Sharp & Dohme Limited Dopamine receptor subtype ligands
US5576319A (en) * 1993-03-01 1996-11-19 Merck, Sharp & Dohme Ltd. Pyrrolo-pyridine derivatives
WO1994020459A2 (en) * 1993-03-01 1994-09-15 Merck Sharp & Dohme Limited Pyrrolo-pyridine derivatives as dopamine receptor ligands
PL310443A1 (en) * 1993-03-01 1995-12-11 Merck Sharp & Dohme Derivatives of pyrolo-pyridine
WO1994020471A1 (en) * 1993-03-05 1994-09-15 Merck Sharp & Dohme Limited Quinolone derivatives as dopamine d4 ligands
GB9416162D0 (en) * 1994-08-10 1994-09-28 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
TW406081B (en) 2000-09-21
AU681310B2 (en) 1997-08-21
NZ290936A (en) 1998-01-26
NO971416L (no) 1997-05-20
HRP950507B1 (en) 2002-06-30
CA2200959C (en) 2000-05-23
JPH09511527A (ja) 1997-11-18
MX9702350A (es) 1997-06-28
FI971310A0 (fi) 1997-03-27
ATE209648T1 (de) 2001-12-15
RU2163239C2 (ru) 2001-02-20
CA2200959A1 (en) 1996-04-11
DE69524241D1 (de) 2002-01-10
ES2166830T3 (es) 2002-05-01
IL115384A (en) 1999-10-28
KR100244848B1 (ko) 2000-03-02
TR199501194A2 (tr) 1996-06-21
WO1996010571A1 (en) 1996-04-11
SK32597A3 (en) 1998-09-09
YU63795A (sh) 1999-03-04
CN1168672A (zh) 1997-12-24
DK0783503T3 (da) 2002-02-11
IL115384A0 (en) 1995-12-31
JP3287574B2 (ja) 2002-06-04
SK284341B6 (sk) 2005-02-04
PE47196A1 (es) 1996-11-11
NO308995B1 (no) 2000-11-27
US5852031A (en) 1998-12-22
HUT77354A (hu) 1998-03-30
UA50720C2 (uk) 2002-11-15
CZ285090B6 (cs) 1999-05-12
CZ94797A3 (cs) 1998-07-15
PL319636A1 (en) 1997-08-18
FI971310A (fi) 1997-03-27
PT783503E (pt) 2002-03-28
SI9520096A (sl) 1998-04-30
HRP950507A2 (en) 1997-08-31
KR970706282A (ko) 1997-11-03
FI113655B (fi) 2004-05-31
EP0783503A1 (de) 1997-07-16
BR9504230A (pt) 1996-08-06
AU3189395A (en) 1996-04-26
MY113729A (en) 2002-05-31
CO4410335A1 (es) 1997-01-09
ZA958223B (en) 1997-04-01
NO971416D0 (no) 1997-03-25
EP0783503B1 (de) 2001-11-28
PL180899B1 (pl) 2001-04-30
CN1068327C (zh) 2001-07-11

Similar Documents

Publication Publication Date Title
ZA915727B (en) Quinuclidine derivatives
ES2164657T3 (es) Derivados aza-biciclicos puenteados como antagonistas de la sustancia p.
ES2092890T3 (es) Aplicacion del riluzol en el tratamiento de la enfermedad de parkinson y de los sindromes de parkinson.
AP1456A (en) Pharmaceutical agents for the treatment of parkinson's disease, ADHD and microadenomas.
DE69524241D1 (de) 2,7,-substituierte octahydro-1h-pyrido[1,2-a]pyrazin derivate
HUP0003118A2 (hu) 2,7-Szubsztituált oktahidro-1H-pirido-[1,2-a]pirazin-származékok alkalmazása gyógyszerkészítmények előállítására
AU693241B2 (en) New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments
DE69215886T2 (de) NEUROLEPTISCH 2-SUBSTITUIERTE PERHYDRO-1H-PYRIDO[1,2-a]PYRAZINE
ES2119454T3 (es) Derivados de pirrolidina para el tratamiento de los desordenes relacionados con la csk y la gastrina.
MX9102181A (es) Iminobenzodiazepina para el tratamiento de desordenes del sueno

Legal Events

Date Code Title Description
8364 No opposition during term of opposition